Voyager Therapeutics (VYGR) Non-Current Assets (2014 - 2026)

Voyager Therapeutics (VYGR) has 13 years of Non-Current Assets data on file, last reported at $72.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 33.04% year-over-year to $72.3 million; the trailing twelve-month figure through Mar 2026 stood at $284.9 million (down 14.07% YoY), and the FY2025 full-year result was $49.6 million, down 57.34% from the prior year.
• Non-Current Assets climbed to $72.3 million in Q1 2026, from $49.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $116.2 million in Q4 2024 to a low of $31.6 million in Q4 2023.
• A 5-year average of $57.0 million and a median of $52.6 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 267.89% in 2024 and slumped 57.34% in 2025, its largest moves.
• Tracing VYGR's Non-Current Assets over 5 years: stood at $34.9 million in 2022, then dropped by 9.35% to $31.6 million in 2023, then jumped by 267.89% to $116.2 million in 2024, then tumbled by 57.34% to $49.6 million in 2025, then jumped by 45.87% to $72.3 million in 2026.
• Business Quant data shows VYGR's Non-Current Assets at $72.3 million in Q1 2026, $49.6 million in Q4 2025, and $68.7 million in Q3 2025.